Chronic Kidney Disease Treatment Market to Reach $47.9 Billion, Globally, by 2032 at 4.0% CAGR: Allied Market Research

Increase in the prevalence of chronic kidney disease (CKD) and technological advancement in chronic kidney disease treatment drive the growth of the global Chronic Kidney Disease Treatment Market. 

PORTLAND, Ore., June 20, 2023 /PRNewswire/ -- Allied Market Research published a report, titled, "Chronic Kidney Disease Treatment Market by Treatment (Drugs and Dialysis), and by End User (Hospitals, Dialysis Centers and Others): Global Opportunity Analysis and Industry Forecast, 2023–2032". According to the report, the global chronic kidney disease treatment market generated $32 billion in 2022, and is anticipated to generate $47.9 billion by 2032, witnessing a CAGR of 4.0% from 2023 to 2032. 

Download Sample Copy- https://www.alliedmarketresearch.com/request-sample/107605 

Prime determinants of growth 

Growing prevalence of chronic kidney disease (CKD) and technological advancement drive the growth of the global Chronic Kidney Disease Treatment Market. However, the high cost of chronic kidney disease (CKD) treatment presents a significant challenge and hampers market growth. On the contrary, the growing healthcare infrastructure and adoption of strategies by key manufacturers are expected to offer remunerative opportunities for expansion of the Chronic Kidney Disease Treatment Market during the forecast period. 

Report coverage & details: 

Covid-19 Scenario 

• Due to the COVID-19 pandemic and the subsequent global lockdowns, the chronic kidney disease treatment market faced a downturn. 
• However, as the global situation started ameliorating, there was a rise in the adoption of in-home dialysis and telemedicine, which in turn presented various growth opportunities for companies operating in the chronic kidney disease treatment market. 

Procure Complete Report at 20% Discount (238 Pages PDF with Insights, Charts, Tables, and Figures) https://www.alliedmarketresearch.com/checkout-final/chronic-kidney-disease-treatment-market

The dialysis segment to maintain its leadership status throughout the forecast period 

Based on treatment, the dialysis segment held the highest market share in 2022, accounting for more than half of the global chronic kidney disease treatment market revenue, and is estimated to maintain its leadership status throughout the forecast period, owing to the rising prevalence of CKD, advancements in dialysis technology, improved healthcare infrastructure, and increased accessibility to reimbursement policies. The same segment is also projected to manifest the highest CAGR of 4.2% from 2023 to 2032. 

The hospitals segment to maintain its lead position during the forecast period 

Based on end-user, the hospitals segment held the largest market share in 2022, accounting for nearly two-fifths of the global chronic kidney disease treatment market revenue, and is estimated to register the highest CAGR of 4.8% throughout the forecast period. This is attributed to the fact that it is a primary healthcare provider and is often equipped with specialized departments and facilities dedicated to the diagnosis, treatment, and management of CKD. 

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/107605 

North America to maintain its dominance by 2032 

Based on region, North America dominated the global chronic kidney disease treatment market in 2022, garnering more than two-fifths of the total revenue, and is expected to continue the trend throughout the forecast period. This is attributed to the rise in the prevalence of CKD, the presence of key players, and the availability of high-quality healthcare system and modern medical technologies. However, Asia-Pacific is expected to register the highest CAGR of 5.0% during the forecast period, owing to the presence of a large patient population, growth in awareness about the potential of chronic kidney disease treatment, and an increase in healthcare funding. 

Leading Market Players: - 

• Astrazeneca Plc
• Pfizer Inc.
• Johnson and Johnson
• F. Hoffmann-La Roche Ltd.
• Baxter International Inc.
• Becton, Dickinson and Company
• B. Braun SE
• Abbvie Inc.
• Teva Pharmaceutical Industries Ltd.
• Fresenius SE And Co. KGaA

The report provides a detailed analysis of these key players of the global chronic kidney disease treatment market. These players have adopted different strategies such as product approval and acquisition to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario. 

Trending Reports in Healthcare Industry:

Proton Therapy Market - Opportunity Analysis and Industry Forecast, 2022–2031

Non Small-Cell Lung Cancer Market- Opportunity Analysis and Industry Forecast, 2022–2031

Allergy Diagnostics Market - Global Opportunity Analysis and Industry Forecast, 2022–2031

Gas Chromatography Market- Global Opportunity Analysis and Industry Forecast, 2022–2031

Electrophoresis Market - Global Opportunity Analysis and Industry Forecast, 2022–2031                                                                 

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model):

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com 

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg